Autoimmunity, infertility and assisted reproductive technologies.

Area of Science:

• Reproductive Medicine
• Immunology
• Infertility Research

Background:

• Many assumptions exist regarding the impact of autoimmunity on fertility and assisted reproductive technologies (ART).
• A robust scientific foundation for these assumptions is often lacking.
• Existing beliefs about autoimmune diseases and infertility require critical evaluation.

Purpose of the Study:

• To critically assess the scientific evidence linking autoimmunity and infertility.
• To evaluate the safety and outcomes of ART in patients with autoimmune diseases.
• To clarify the risks associated with ART pregnancies in the context of autoimmune conditions.

Main Methods:

• Review of existing scientific literature and clinical data.
• Analysis of studies on infertility in patients with autoimmune diseases.
• Examination of ART outcomes in women with pre-existing autoimmune conditions.

Main Results:

• Evidence does not strongly support autoimmunity as a cause of infertility.
• ART appears safe for carefully selected patients with autoimmune diseases, though risks like OHSS and multiple pregnancies exist.
• Stable autoimmune diseases without organ damage likely do not impact ART pregnancy outcomes.
• Children born from ART pregnancies involving mothers with autoimmune disease appear normal at birth, pending long-term data.
• Male fertility is unlikely to be significantly affected by autoimmune disease.

Conclusions:

• Current scientific evidence does not substantiate a causal link between autoimmunity and infertility.
• Assisted reproductive technologies can be safely employed in selected patients with autoimmune diseases under careful monitoring.
• Further long-term studies are needed to fully understand the implications of autoimmune diseases on ART outcomes and offspring health.